Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

INTRODUCTION: The efficacy of sarilumab and upadacitinib, in combination with disease-modifying antirheumatic drugs (DMARDs), was demonstrated in phase 3 clinical trials of patients with rheumatoid arthritis (RA) refractive to previous biologic DMARDs. In the absence of head-to-head clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huizinga, Thomas, Choy, Ernest, Praestgaard, Amy, van Hoogstraten, Hubert, LaFontaine, Patrick R., Guyot, Patricia, Aletaha, Daniel, Müller-Ladner, Ulf, Tanaka, Yoshiya, Curtis, Jeffrey R., Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140231/
https://www.ncbi.nlm.nih.gov/pubmed/36725768
http://dx.doi.org/10.1007/s40744-022-00521-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140231/
https://www.ncbi.nlm.nih.gov/pubmed/36725768
http://dx.doi.org/10.1007/s40744-022-00521-1

Ejemplares similares